Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 139 for Epilepsy

Edit search filters
  1. Efficacy, Safety, Tolerability, And Pharmacokinetics Of NBI-827104 In Pediatric Subjects With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep

    Rochester, MN

  2. Perampanel For The Reduction Of Seizure Frequency In Patients With High-grade Glioma And Focal Epilepsy

    Jacksonville, FL

  3. Adjunctive GNX Treatment Compared With Placebo In Children And Adults With TSC-related Epilepsy

    Rochester, MN

  4. Allogenic Adipose-Derived Mesenchymal Stem Cells For Epilepsy During Deep Brain Stimulation Surgery

    Jacksonville, FL

  5. A Study To Assess The Safety Of NRL-1 For The Treatment Of People With Epilepsy

    Rochester, MN

  6. A Study To Investigate The Safety And Tolerability Of Single And Multiple Ascending Doses Of Antisense Oligonucleotide STK-001 In Children And Adolescents With Dravet Syndrome

    Rochester, MN

  7. A Study To Investigate The Long-Term Safety Of ZX008 (Fenfluramine Hydrochloride) Oral Solution In Children And Adults With Epileptic Encephalopathy Including Dravet Syndrome And Lennox-Gastaut Syndrome

    Rochester, MN

  8. A Study To Test The Effectiveness And Safety Of Padsevonil As Treatment Of Focal-onset Seizures In Adult Subjects With Drug-resistant Epilepsy

    Rochester, MN

  9. Patient Experiences of Neuromodulation for Epilepsy

    Rochester, MN

  10. Retrospective SUDEP At Epilepsy Centers

    Rochester, MN

.

Mayo Clinic Footer